Novita Pharmaceuticals
New York, US · Delaware corporation
Founders & leadership
CY
Christy Y. ShueExecutive
DM
David MoyExecutive
JJ
Jue Jullian ZhangExecutive
Board
CL
Chenjian LiBoard director
XH
Xin-Yun HuangBoard director
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 2 rounds · 2016–2019
▶$2.4MraisedOct 2020 · 20 investors · BiotechnologyRule 506(b)
▶$2.4MraisedOct 2020 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xin-Yun HuangDirector
- David MoyExecutive Officer
- Chenjian LiDirector
- Christy Y. ShueExecutive Officer, Director
- Jonathan Jia ZhuDirector
- Jue Jillian ZhangExecutive Officer, Director
- Amount sold
- $2.4M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedApr 2017 · 30 investors · BiotechnologyRule 506(b)
▶$6.5MraisedApr 2017 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chenjian LiDirector
- Christy Y. ShueExecutive Officer, Director
- David MoyExecutive Officer
- Jue Jullian ZhangExecutive Officer, Director
- Xin-Yun HuangDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Minimum investment
- $50.6K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Novita Pharmaceuticals raised?
- Novita Pharmaceuticals has disclosed $8.9M raised across 2 rounds.
- Where is Novita Pharmaceuticals headquartered?
- Novita Pharmaceuticals is headquartered in New York, US.